» Articles » PMID: 23656586

Sturge-Weber Syndrome and Port-wine Stains Caused by Somatic Mutation in GNAQ

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2013 May 10
PMID 23656586
Citations 366
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Sturge-Weber syndrome is a sporadic congenital neurocutaneous disorder characterized by a port-wine stain affecting the skin in the distribution of the ophthalmic branch of the trigeminal nerve, abnormal capillary venous vessels in the leptomeninges of the brain and choroid, glaucoma, seizures, stroke, and intellectual disability. It has been hypothesized that somatic mosaic mutations disrupting vascular development cause both the Sturge-Weber syndrome and port-wine stains, and the severity and extent of presentation are determined by the developmental time point at which the mutations occurred. To date, no such mutation has been identified.

Methods: We performed whole-genome sequencing of DNA from paired samples of visibly affected and normal tissue from 3 persons with the Sturge-Weber syndrome. We tested for the presence of a somatic mosaic mutation in 97 samples from 50 persons with the Sturge-Weber syndrome, a port-wine stain, or neither (controls), using amplicon sequencing and SNaPshot assays, and investigated the effects of the mutation on downstream signaling, using phosphorylation-specific antibodies for relevant effectors and a luciferase reporter assay.

Results: We identified a nonsynonymous single-nucleotide variant (c.548G→A, p.Arg183Gln) in GNAQ in samples of affected tissue from 88% of the participants (23 of 26) with the Sturge-Weber syndrome and from 92% of the participants (12 of 13) with apparently nonsyndromic port-wine stains, but not in any of the samples of affected tissue from 4 participants with an unrelated cerebrovascular malformation or in any of the samples from the 6 controls. The prevalence of the mutant allele in affected tissues ranged from 1.0 to 18.1%. Extracellular signal-regulated kinase activity was modestly increased during transgenic expression of mutant Gαq.

Conclusions: The Sturge-Weber syndrome and port-wine stains are caused by a somatic activating mutation in GNAQ. This finding confirms a long-standing hypothesis. (Funded by the National Institutes of Health and Hunter's Dream for a Cure Foundation.).

Citing Articles

The Triad of Blood-Brain Barrier Integrity: Endothelial Cells, Astrocytes, and Pericytes in Perinatal Stroke Pathophysiology.

Garcia-Martinez T, Gornatti D, Ortiz M, Canellas G, Heine-Suner D, Vives-Bauza C Int J Mol Sci. 2025; 26(5).

PMID: 40076511 PMC: 11900453. DOI: 10.3390/ijms26051886.


Evolutionary Trends and Research Focal Points on Port Wine Stains: A Scientometric and Meta-Analysis.

Su Z, Chen X, Zhang R, Li J, Zhou Z, Bi J J Cosmet Dermatol. 2025; 24(2):e16770.

PMID: 39918133 PMC: 11804166. DOI: 10.1111/jocd.16770.


A case report of macular coloboma as an ocular clinical feature in Sturge Weber Syndrome.

Alhussain B, Alsubaie H, Owaidhah O Int J Surg Case Rep. 2024; 126():110750.

PMID: 39700584 PMC: 11722906. DOI: 10.1016/j.ijscr.2024.110750.


Sturge-Weber syndrome: updates in translational neurology.

Solomon C, Comi A Front Neurol. 2024; 15:1493873.

PMID: 39687400 PMC: 11646805. DOI: 10.3389/fneur.2024.1493873.


Laser and light-based treatments for port-wine birthmarks - a systematic review and network meta-analysis.

Nguyen L, Sorbe C, Schoen G, Schneider S, Herberger K J Dtsch Dermatol Ges. 2024; 23(3):293-301.

PMID: 39668417 PMC: 11887003. DOI: 10.1111/ddg.15612.


References
1.
Kajio F, Nakazawa M . Vascular effects of endothelin-1 in stage 21 chick embryos. Heart Vessels. 1997; 12(6):300-5. DOI: 10.1007/BF02766807. View

2.
Happle R . Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol. 1987; 16(4):899-906. DOI: 10.1016/s0190-9622(87)80249-9. View

3.
Conklin B, Chabre O, Wong Y, Federman A, Bourne H . Recombinant Gq alpha. Mutational activation and coupling to receptors and phospholipase C. J Biol Chem. 1992; 267(1):31-4. View

4.
Shirazi F, Cohen C, Fried L, Arbiser J . Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo. Lymphat Res Biol. 2008; 5(4):233-6. DOI: 10.1089/lrb.2007.1012. View

5.
Coleman D, Berghuis A, Lee E, Linder M, GILMAN A, Sprang S . Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. Science. 1994; 265(5177):1405-12. DOI: 10.1126/science.8073283. View